期刊文献+

聚合物纳米粒子载药体系的研究进展 被引量:5

Study on polymer nanoparticles in drug delivery system
下载PDF
导出
摘要 聚合物纳米粒子是一种新型的药物载体,具有小粒子特征,可以穿越生物膜屏障, 到达传统药物无法到达的人体特定部位,建立起新的给药途径;聚合物载体的多变性又可赋予药物许多新的特点,因而引起广泛关注。按预聚物分散和单体聚合2种方法,介绍了载药聚合物纳米粒子的制备方法以及粒子的表面修饰;描述了粒子的粒度、形貌、相对分子质量、Zeta电位及热性能的表征方法;介绍了其应用现状;对聚合物纳米粒子载药体系的发展方向提出了建议。 Polymer nanoparticles as drug carrier systems is a new kind of drug delivery system. It is easy to get to site-specific through biofilm barrier for the nanoparticles. Polymer nanoparticles have new characteristics for multiformity of polymeric material, so polymer nanoparticles employed as drug carriers have attracted attention. In this review, the two preparative methods for dispersion of the preformed polymers and polymerization of monomers are expounded, the measuring method of particles diameter,modality,moleculer weight,Zeta potential and thermic performance are investigated, and the applications are discussed. At last are the suggestions on development trend for polymer nanoparticles as drug carrier.
出处 《河北工业科技》 CAS 2005年第1期38-43,共6页 Hebei Journal of Industrial Science and Technology
基金 河北省科技攻关项目(03215101D)
关键词 载药 聚合物纳米粒 传统药物 特定部位 研究进展 给药途径 药物载体 预聚物 粒子 新型 polymer nanoparticles drug carriers preparation methods performance applications
  • 相关文献

参考文献40

  • 1张志荣,龚艳,黄园,何勤.抗人乳腺癌单克隆抗体偶联米托蒽醌白蛋白纳米球的初步研究[J].药学学报,2001,36(2):151-154. 被引量:18
  • 2LEROUX J C, ALLEMANN E, JAEGHERE F D, et al.Biodegradable nanopartides from sustained release formulations to improved site-specific drug delivery[J]. Control Re-lease, 1996, 39: 339-350.
  • 3REDHEAD H M,DAVIS S S,ILLUM L. Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908.- in vitro characteristics and in vivo evalution[J]. Control Release, 2001,70: 353-363.
  • 4PERACCHIA M T, FATTAL E, DESMAELE D, et al. PE gylated polycyanocarylate nanopartieles for intravenous administration and splenic targeting[J]. Control Rdease, 1999,60:121-128.
  • 5STELLA B, ARPICCO S, PERACCHIA M T,et al. Design of folic acid-conjugated nanoparticles for drug targeting[J].Pharm Sci, 2000,89:1452-1464.
  • 6MONTISCI M J, GIOVANNUCI G, DUCHENE D, et al.Covalent coupling of asparagus pea and tomato lectins to poly(lactide) microspheres[J]. Int J Pharm,2001,215 : 153-161.
  • 7EZPELETA L, IRCHE J, ORECCHIONI A. Preparation of lectin-vicilin naoparticles conjugates using the carbodiimide coupling technique[J]. Int J Pharm,1996,142:227-233.
  • 8ENIOLA A O, RODGERS S D, HAMMER D A. Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytes[J]. Biomaterials, 2002,23:2167-2 177.
  • 9ZHANG Y, KOHLER N, ZHANG M. Surface modification of superparamagnetie magnetite nanopartieles and their intracellular[J]. Biomaterials, 2002,23:1 553-1 561.
  • 10DAWSON G F, HALBERT W. The in vitro cell associationof invasion coated polylactide-co-glycolide nanoparticles[J].Pharm Res, 2000,17:1420-1425.

二级参考文献6

  • 1Wang W G,药学学报,1995年,30卷,8期,583页
  • 2Gu X Z,现代肿瘤学,1993年,18页
  • 3Longo W E,Methods Enzymol,1985年,112卷,1期,18页
  • 4Longo W E,J Pharm Sci,1982年,71卷,12期,1323页
  • 5Zee Cheng C,J Med Chem,1979年,21卷,3期,291页
  • 6Jan C,Biochem J,1978年,173卷,10期,723页

共引文献17

同被引文献51

引证文献5

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部